Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02689921
Title NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer (NEOADAPT)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Midwestern Regional Medical Center
Indications

Her2-receptor positive breast cancer

Therapies

Anastrozole

Letrozole

Leuprolide

Pertuzumab + Trastuzumab

Exemestane

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.